Description
IGF::OT::IGF BLOOD CULTURE CPRT FOR VISN 11
First action · last action
2015-10-01 · 2015-10-01
Transactions
1
First transaction's obligation
$18,470
Base + all options value (sum of deltas)
$18,470
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA25114A0014
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-10-01+$18,470= $18,470
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-10-01 | +$18,470 | $18,470 | IGF::OT::IGF BLOOD CULTURE CPRT FOR VISN 11 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI HCNVCMEG9NL6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926F0276 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $60,940 | FY2026 |
| 36C25726N0441 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $122,631 | FY2026 |
| 36C25726D0091 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $0 | FY2026 |
| 36C26226N0903 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $67,946 | FY2026 |
| 36C24926N0666 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $982,841 | FY2026 |
| 36C24126N0842 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $310,739 | FY2026 |
Other recipients under W065 from 655-SAGINAW (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25116F0401 | SIEMENS MEDICAL SOLUTIONS USA, INC. | 655-SAGINAW | $20,704 | FY2016 |
| VA25116P0400 | CARESTREAM HEALTH, INC | 655-SAGINAW | $20,056 | FY2016 |
| VA25116F0280 | SIEMENS MEDICAL SOLUTIONS USA, INC. | 655-SAGINAW | $60,508 | FY2016 |
| VA25116P0202 | ARKRAY USA INC | 655-SAGINAW | $5,500 | FY2016 |
| VA25116P0185 | BECKMAN COULTER, INC. | 655-SAGINAW | $16,236 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25115J2631_3600_VA25114A0014_3600 · retrieved 2026-09-26.